Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Insys Therapeutics, Inc. (NASDAQ:INSY) announced that the FDA has granted orphan drug status to its pharmaceutical cannabidiol (CBD), for the treatment of glioblastoma multiforme (GBM.V). Glioblastoma multiforme is the most common and aggressive form of malignant primary brain tumor. INSYS Therapeutics, Inc. (NASDAQ:INSY) belongs to Healthcare sector. Its net profit margin is 31.70% and weekly performance is -4.03%. On last trading day company shares ended … Continue reading Active Watch List: INSYS Therapeutics (NASDAQ:INSY), Celladon Corporation (NASDAQ:CLDN), WisdomTree Investments, Inc. (NASDAQ:WETF), Arotech Corporation (NASDAQ:ARTX), DigitalGlobe, Inc. (NYSE:DGI)

Jason Knox09/03

Watch List : Denbury Resources (NYSE:DNR), Celladon (NASDAQ:CLDN), Comerica (NYSE:CMA), Post Properties (NYSE:PPS), Bob Evans Farms (NASDAQ:BOBE)

Denbury Resources (NYSE:DNR) posted its quarterly earnings results on Wednesday. The company reported $0.26 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.27 by $0.01, AR Network reports. The company had revenue of $669.00 million for the quarter, compared to the consensus estimate of $628.06 million. Denbury Resources Inc. (NYSE:DNR) belongs to Basic Materials sector. Its net profit margin is 14.80% and … Continue reading Watch List : Denbury Resources (NYSE:DNR), Celladon (NASDAQ:CLDN), Comerica (NYSE:CMA), Post Properties (NYSE:PPS), Bob Evans Farms (NASDAQ:BOBE)

Jason Knox08/07